Exchange: NASDAQ·Updated 04:59 AM EDT
NVAX logo

NVAX Novavax Inc

$10.28
$0.06
(0.58%)
Pre-Market
Prev Close $10.34
Reported EarningsAug 6
Mkt Cap$1.7B
Vol1,033.00

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
65

Bullish Sentiment

How do you feel about NVAX?

Advertisement|Remove ads.